Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

Mikhail Kosiborod, Russell Esterline, Remo H.M. Furtado, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch, Felipe A. Martínez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Joan Buenconsejo, Anna Maria Langkilde, Phil Ambery, Fengming Tang, Kensey Gosch, Sheryl L. Windsor, Emily E Akin, Ronaldo V P Soares, Diogo D F Moia, Matthew Aboudara, Conrado Roberto Hoffmann Filho, Audes D. M. Feitosa, Alberto Fonseca, Vishnu Garla, Robert Gordon, Ali Javaheri, Cristiano Pederneiras Jaeger, Paulo Leães, Michael E. Nassif, Michael Pursley, Fábio Serra Silveira, Weimar Kunz Sebba Barroso, José Roberto Lazcano Soto, Lília Nigro Maia, Otávio Berwanger